Presentation TVT 2017 The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy Presenter: George D. Dangas June 16, 2017 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TVT 2017 TAVR Up Next Presentation TVT 2017 Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials Presenter: Philippe Pibarot June 16, 2017 More slides + Presentation TVT 2017 A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability Presenter: Hendrik Treede June 16, 2017 Presentation TVT 2017 Will the Heart Team Survive the Modern Era of Minimalist TAVR? Presenter: Wilson Y. Szeto June 16, 2017 We Recommend
Presentation TVT 2017 Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials Presenter: Philippe Pibarot June 16, 2017
Presentation TVT 2017 A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability Presenter: Hendrik Treede June 16, 2017
Presentation TVT 2017 Will the Heart Team Survive the Modern Era of Minimalist TAVR? Presenter: Wilson Y. Szeto June 16, 2017